Correlation Between Rezolute and Processa Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Rezolute and Processa Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Processa Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Rezolute and Processa Pharmaceuticals, you can compare the effects of market volatilities on Rezolute and Processa Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Processa Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Processa Pharmaceuticals.

Diversification Opportunities for Rezolute and Processa Pharmaceuticals

-0.21

Correlation Coefficient

Rezolute  Processa Pharmaceuticals

Very good diversification

The 3 months correlation between Rezolute and Processa is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Processa Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Processa Pharmaceuticals and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Processa Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Processa Pharmaceuticals has no effect on the direction of Rezolute i.e., Rezolute and Processa Pharmaceuticals go up and down completely randomly.

Pair Corralation between Rezolute and Processa Pharmaceuticals

Given the investment horizon of 90 days Rezolute is expected to generate 0.43 times more return on investment than Processa Pharmaceuticals. However, Rezolute is 2.31 times less risky than Processa Pharmaceuticals. It trades about 0.15 of its potential returns per unit of risk. Processa Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  88.00  in Rezolute on September 13, 2024 and sell it today you would earn a total of  407.00  from holding Rezolute or generate 462.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Rezolute  vs.  Processa Pharmaceuticals

Rezolute

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Rezolute has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Rezolute is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Processa Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Processa Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Processa Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Rezolute and Processa Pharmaceuticals

The main advantage of trading using opposite Rezolute and Processa Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Processa Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Processa Pharmaceuticals will offset losses from the drop in Processa Pharmaceuticals' long position.

The idea behind Rezolute and Processa Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.